Newcastle Disease, Infectious Bronchitis,Avian Influenza (Subtype H9) , Fowl Adenovirus And Infectious Bursal Disease Five-valent Vaccine, Inactivated
- China’s top vaccine factory
- Support Inspection Factory
- OEM/ODM, Wholesale
- Certificate: ISO, CQC, GMP, FDA
- On-Time Delivery
- Free Sample
- 7/24 Hours Free Customer Service
Generic name of product
Newcastle Disease, Infectious Bronchitis,Avian Influenza (Subtype H9) , Fowl Adenovirus And Infectious Bursal Disease Five-valent Vaccine, Inactivated
Main Ingredients and Content
The vaccine contains the inactivated Newcastle Disease Virus (sub-genotype VII) with a viral titer of ≥ 3×109.0EID50/0.1mL (before inactivation), Infectious Bronchitis virus strain QX (the content before inactivation ≥ 1×107.5EID50/0.1mL),the inactivated Avian Influenza Virus (H9N2 subtype clade 4.1.a and 4.1.b) both with a viral titer of ≥ 3×109.0EID50/0.1mL (before inactivation), Fowl Adenovirus subunit antigen concentration：Fibre protein Type C4≥108.5TCID50/0.1mL, Fibre proteinType E 8a/8b≥108.0TCID50/0.1mL, Fibre protein Type D11≥108.0TCID50/0.1mL.the VP2 protein content of Infectious Bursal Disease Virus in is 10μg /0.1 mL.
Character
Milky white uniform emulsion
Functions and Uses
Used for the prevention of Newcastle Disease(sub-genotype VII), Infectious Bronchitis virus strain QX，Avian Influenza (H9N2 subtype clade 4.1.a and 4.1.b),Fowl Adenovirus（I GROUP Type C4、TypeE 8a/8b、Type D11) and Infectious Bursal Disease Virus. Immunity is generated 14–21 days after immunization, with an immune period of 3 months.
Usage and Dosage
Administer via subcutaneous injection in the neck or intramuscular injection.
For chickens aged 1-4 weeks: 0.3ml/dose
For chickens over 4 weeks of age: 0.5ml/dose
[Adverse Reactions]:Generally, no visible adverse reactions occur
Adverse Reactions
Generally, no visible adverse reactions occur
Precautions
- 1. Inoculate healthy chickens only. It is forbidden to use in emaciated and diseased chickens.
- 2. Check carefully for broken bottles, absent label, impurity in vaccine, severe separation of water phase and oil phase, and other abnormal conditions before use, if any, do not use.
- 3. Allow the vaccine to room temperature and shake well before use.
- 4. After the vaccine bottle is first opened, use up the vaccine within 2 hours, avoiding contamination.
- 5. The vaccine shouldn’t be frozen.
- 6. Instruments such as the needles and syringes for the injection of the product need to be disinfected by pressured steam or boiling.
- 7. The vaccine should be combined with live Newcastle disease and infectious bronchitis vaccines to improve cell-mediated immunity and mucosal immunity.
Storage and Period of Validity
2-8℃ preservation, valid for 24 months.
Specifications
(1)250mL/bottle, 40bottles/carton (2)500mL/bottle, 20bottles/carton
Only under the guidance of the veterinary use
Features
After a decade of R&D, WollVac’s latest product makes its grand launch in 2025. Offering “one injection for five protections,” it enhances epidemic prevention efficiency and effectiveness. Featuring carefully selected strains and viral composite subunit antigens, this innovative solution is a pioneering breakthrough in China. Formulated with a composite adjuvant, it leverages the advantages of compound vegetable oil to ensure zero stress on animals.
The use of complex antigens:
Serotype matching is essential for effective vaccine protection. Using real-time data from the Shandong Provincial Engineering Laboratory for Animal Pathogenic Microorganisms Testing Center, the R&D Center evaluates prevalent strains from the epidemic pathogen bank through multiple stages—preliminary lab screening, animal testing, and cross-protective antibody assessment. The selected dominant strains ensure broad and high-efficacy protection.
| Antigen | ND | IB | AI H9N2 | FADV | IBDV |
|---|---|---|---|---|---|
| Strain | VII type | QX | h 9.4.1.a + h 9.4.1.b | C4 + E8b + D11 | cvvIBDV + nvIBDV |
| Strain | VII type | QX | h 9.4.2.5b + h 9.4.2.5c | C4 + E8b + D11 | cvvIBDV + nvIBDV |